TP53 codon 72 polymorphism associated with prognosis in patients with advanced gastric cancer treated with paclitaxel and cisplatin.
Kim JG, Sohn SK, Chae YS, Song HS, Kwon KY, Do YR, Kim MK, Lee KH, Hyun MS, Lee WS, Sohn CH, Jung JS, Kim GC, Chung HY, Yu W.
Kim JG, et al. Among authors: kim gc, kim mk.
Cancer Chemother Pharmacol. 2009 Jul;64(2):355-60. doi: 10.1007/s00280-008-0879-3. Epub 2008 Dec 4.
Cancer Chemother Pharmacol. 2009.
PMID: 19052714